“Benefit of Using Renal Sodium-Glucose Cotransporter Inhibitors 2 (iSGLT-2) in Patients With Type 2 Diabetes Mellitus and Heart Failure”. Electronic Journal Collection Health 12, no. 9 (September 25, 2020): e4349. Accessed November 3, 2026. https://acervomais.com.br/saude/article/view/4349.